Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Rheumatoid Arthritis
|
676 | 0.472 | 0.920 | 6 | 31575254 | upstream gene variant | G/A | snv | 0.12 | 0.14 | 0.070 | 0.857 | 7 | 2011 | 2019 | ||||
Lymphoma, Non-Hodgkin
|
193 | 0.472 | 0.920 | 6 | 31575254 | upstream gene variant | G/A | snv | 0.12 | 0.14 | 0.060 | 1.000 | 6 | 2007 | 2015 | ||||
cervical cancer
|
257 | 0.472 | 0.920 | 6 | 31575254 | upstream gene variant | G/A | snv | 0.12 | 0.14 | 0.050 | 0.800 | 5 | 2012 | 2018 | ||||
Cervix carcinoma
|
266 | 0.472 | 0.920 | 6 | 31575254 | upstream gene variant | G/A | snv | 0.12 | 0.14 | 0.050 | 0.800 | 5 | 2012 | 2018 | ||||
Malignant tumor of cervix
|
245 | 0.472 | 0.920 | 6 | 31575254 | upstream gene variant | G/A | snv | 0.12 | 0.14 | 0.050 | 0.800 | 5 | 2012 | 2018 | ||||
Septicemia
|
139 | 0.472 | 0.920 | 6 | 31575254 | upstream gene variant | G/A | snv | 0.12 | 0.14 | 0.050 | 1.000 | 5 | 2008 | 2017 | ||||
Chronic Obstructive Airway Disease
|
301 | 0.472 | 0.920 | 6 | 31575254 | upstream gene variant | G/A | snv | 0.12 | 0.14 | 0.040 | 1.000 | 4 | 2010 | 2019 | ||||
Diabetes Mellitus, Insulin-Dependent
|
388 | 0.472 | 0.920 | 6 | 31575254 | upstream gene variant | G/A | snv | 0.12 | 0.14 | 0.040 | 0.500 | 4 | 2006 | 2019 | ||||
Malignant neoplasm of stomach
|
603 | 0.472 | 0.920 | 6 | 31575254 | upstream gene variant | G/A | snv | 0.12 | 0.14 | 0.040 | 1.000 | 4 | 2013 | 2017 | ||||
Malignant Neoplasms
|
1441 | 0.472 | 0.920 | 6 | 31575254 | upstream gene variant | G/A | snv | 0.12 | 0.14 | 0.040 | 0.750 | 4 | 2013 | 2017 | ||||
Primary malignant neoplasm
|
1374 | 0.472 | 0.920 | 6 | 31575254 | upstream gene variant | G/A | snv | 0.12 | 0.14 | 0.040 | 0.750 | 4 | 2013 | 2017 | ||||
Sepsis
|
139 | 0.472 | 0.920 | 6 | 31575254 | upstream gene variant | G/A | snv | 0.12 | 0.14 | 0.040 | 1.000 | 4 | 2012 | 2017 | ||||
Stomach Carcinoma
|
616 | 0.472 | 0.920 | 6 | 31575254 | upstream gene variant | G/A | snv | 0.12 | 0.14 | 0.040 | 1.000 | 4 | 2013 | 2017 | ||||
Ankylosing spondylitis
|
273 | 0.472 | 0.920 | 6 | 31575254 | upstream gene variant | G/A | snv | 0.12 | 0.14 | 0.030 | 1.000 | 3 | 2018 | 2018 | ||||
Asthma
|
714 | 0.472 | 0.920 | 6 | 31575254 | upstream gene variant | G/A | snv | 0.12 | 0.14 | 0.030 | 1.000 | 3 | 2012 | 2014 | ||||
Colorectal Carcinoma
|
1186 | 0.472 | 0.920 | 6 | 31575254 | upstream gene variant | G/A | snv | 0.12 | 0.14 | 0.030 | 0.667 | 3 | 2017 | 2019 | ||||
Coronary heart disease
|
769 | 0.472 | 0.920 | 6 | 31575254 | upstream gene variant | G/A | snv | 0.12 | 0.14 | 0.030 | 0.667 | 3 | 2013 | 2019 | ||||
Degenerative polyarthritis
|
178 | 0.472 | 0.920 | 6 | 31575254 | upstream gene variant | G/A | snv | 0.12 | 0.14 | 0.030 | 1.000 | 3 | 2013 | 2018 | ||||
Inflammatory Bowel Diseases
|
277 | 0.472 | 0.920 | 6 | 31575254 | upstream gene variant | G/A | snv | 0.12 | 0.14 | 0.030 | 1.000 | 3 | 2016 | 2017 | ||||
Leprosy
|
75 | 0.472 | 0.920 | 6 | 31575254 | upstream gene variant | G/A | snv | 0.12 | 0.14 | 0.030 | 1.000 | 3 | 2015 | 2017 | ||||
Lupus Erythematosus, Systemic
|
635 | 0.472 | 0.920 | 6 | 31575254 | upstream gene variant | G/A | snv | 0.12 | 0.14 | 0.030 | 0.667 | 3 | 2018 | 2019 | ||||
Metabolic Syndrome X
|
477 | 0.472 | 0.920 | 6 | 31575254 | upstream gene variant | G/A | snv | 0.12 | 0.14 | 0.030 | 1.000 | 3 | 2010 | 2018 | ||||
Tuberculosis, Pulmonary
|
171 | 0.472 | 0.920 | 6 | 31575254 | upstream gene variant | G/A | snv | 0.12 | 0.14 | 0.030 | 0.667 | 3 | 2011 | 2017 | ||||
Acute periodontitis
|
49 | 0.472 | 0.920 | 6 | 31575254 | upstream gene variant | G/A | snv | 0.12 | 0.14 | 0.020 | 1.000 | 2 | 2014 | 2016 | ||||
Aggressive Periodontitis
|
55 | 0.472 | 0.920 | 6 | 31575254 | upstream gene variant | G/A | snv | 0.12 | 0.14 | 0.020 | 1.000 | 2 | 2014 | 2016 |